Q&A With the new
– Youjie Zhang
Thomas Lockhart. May 29, 2020
Why did you decide to join the company?
I am a firm believer that “we can’t solve problems by using the same kind of thinking we used when we created them”. I was looking for an organization which could bring new insights and know-how across industries in the new digital era. At the same time, I contribute with my project and product management expertise from life science.
Nodes (as part of the Monstar Lab group) is a company with rich experience and it has a special focus on the life science sector. With a unique combination of UX and digital development competences, Nodes is an exciting company to join.
What is your new role and what will your primary focus be?
I am the Delivery Director of digital projects for Life Science companies. My primary focus is to inspire Life Science customers supported by talented colleagues from Nodes. With Nodes’ more than 1000 successful digital projects experience, our customers don’t have to reinvent the wheel, and we don’t necessarily have to “think out of box”. We just need to think outside the life science building and get inspired by other industries; That will benefit the life science companies tremendously. Along with this, deliver Nodes’ service as promised, so that our customers feel our great customer experience.
What characterises the pharmaceutical/life science sector at the moment?
The life science sector is on the learning curve on how to adapt to the new digital world. Many companies have started their own innovation labs or initiatives and based on their industry knowledge they are trying new ways, digital ways, to engage with their stakeholders, both internally and externally. This goes to digitize internal business administration processes, drug development, clinical trials, manufacturing, supply chain, marketing, medical devices, etc. through different digital technologies. This is also strongly supported by regulators and governments.
Yet, there is a very unique characteristic in life science from the patients’ perspective. Not a single person would like to have any health issues, and no one, including their family, would prefer to engage further with their health issues if they could avoid that. It’s not about the digital product, it’s about knowing the patient and improving their experience towards better health and a normal life.
Looking into the crystal ball, what will happen to the pharmaceutical/life science sector in the future?
As William Gibson said, “the future is already here — it’s just not very evenly distributed”. In this digital world, the life science sector is no exception. The trend is that the companies who are winning through exceeding expectations, who are leveraging digital technologies to offer personalised multi-channel interaction with their customers (internal employees, HCPs, patients, patients family, communities, etc.) and who are creating better customer experiences will have a sustainable business. CX is the telescope to see the “future”; Design Thinking is the “how”.
MSc in Computer Systems Engineering